Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Cancer Research
|
December 14, 2011
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer
Terence W Friedlander, Ritu Roy, Scott A Tomlins, et al.
BMC Cancer
|
August 30, 2020
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer
Clinton L Cario, Emmalyn Chen, Lancelote Leong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2020
Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study
Edwin M Posadas, Kim N Chi, Ronald de Wit, et al.
Clinical Genitourinary Cancer
|
October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
Mina Lee, Haemin Hong, Won Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients
Chloe E Atreya, Eric A Collisson, Meyeon Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2014
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens
Won Kim, Li Zhang, John H Wilton, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
Meenal Sinha, Li Zhang, Sumit Subudhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
Future Oncology (London, England)
|
November 23, 2023
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
Cancer Immunology Research
|
October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer
Xiao X Wei, Stephen Chan, Serena Kwek, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Cancer Research
|
December 14, 2011
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer
Terence W Friedlander, Ritu Roy, Scott A Tomlins, et al.
BMC Cancer
|
August 30, 2020
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer
Clinton L Cario, Emmalyn Chen, Lancelote Leong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2020
Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase Ib Study
Edwin M Posadas, Kim N Chi, Ronald de Wit, et al.
Clinical Genitourinary Cancer
|
October 18, 2018
Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
Mina Lee, Haemin Hong, Won Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients
Chloe E Atreya, Eric A Collisson, Meyeon Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2014
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens
Won Kim, Li Zhang, John H Wilton, et al.
Journal for Immunotherapy of Cancer
|
May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
Meenal Sinha, Li Zhang, Sumit Subudhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
Future Oncology (London, England)
|
November 23, 2023
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
Cancer Immunology Research
|
October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer
Xiao X Wei, Stephen Chan, Serena Kwek, et al.
Page
of 5